Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,704,158 papers from all fields of science
Search
Sign In
Create Free Account
efalizumab
Known as:
anti alphaL integrin
, antiCD11 alpha
, efalizumab [Chemical/Ingredient]
A humanized IgG1 monoclonal antibody directed against CD11a, the alpha subunit of human leukocyte-function-associated antigen type 1 (LFA-1), with…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Monoclonal Antibodies
antigen binding
hu1124
Narrower (1)
Raptiva
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
A retrospective analysis of 72 patients on prior efalizumab subsequent to the time of voluntary market withdrawal in 2009.
E. Prater
,
A. Day
,
Mahir Patel
,
A. Menter
Journal of Drugs in Dermatology
2014
Corpus ID: 24811516
BACKGROUND Efalizumab was voluntarily withdrawn from the market in April 2009 after four cases of progressive multifocal…
Expand
2014
2014
Erratum to: T-Cell Trafficking and Anti-Adhesion Strategies in Inflammatory Bowel Disease: Current and Future Prospects
M. Mosli
,
J. Rivera-Nieves
,
B. Feagan
Drugs
2014
Corpus ID: 46953237
Review
2010
Review
2010
Handbook of therapeutic antibodies : technologies, emerging developments and approved therapeutics
S. Dübel
2010
Corpus ID: 68720881
Section I: Technologies Foreword A Greeting from the Editor PART 0: INTRODUCTION Therapeutic Antibodies - From Past to Future…
Expand
2009
2009
Recurrent angioedema associated with efalizumab.
L. Mallbris
,
Fredrik von Bergen
,
M. van Hage
,
M. Ståhle
Acta Dermato-Venereologica
2009
Corpus ID: 31496904
© 2009 The Authors. doi: 10.2340/00015555-0715 Journal Compilation © 2009 Acta Dermato-Venereologica. ISSN 0001-5555 Sir…
Expand
2008
2008
Efalizumab-induced lupus-like syndrome.
H. Durox
,
A. Sparsa
,
+5 authors
C. Bédane
Acta Dermato-Venereologica
2008
Corpus ID: 11120412
This article does not have an abstract.
2008
2008
Cytomegalovirus complicating biological immunosuppressive therapy in two patients with psoriasis receiving treatment with etanercept or efalizumab.
B. Petersen
,
H. Lorentzen
Acta Dermato-Venereologica
2008
Corpus ID: 39532107
Cytomegalovirus (CMV) is a herpes virus with life-long persistence following primary infection. Forty percent of the population…
Expand
2008
2008
Efalizumab-associated Guillain-Barre syndrome.
Frank C. Victor
,
Kavita Menon
,
Jo-Ann M. Latkowski
,
A. Fernández-Obregón
,
B. Strober
Archives of Dermatology
2008
Corpus ID: 29941878
2008
2008
Merkel cell carcinoma presenting as lymphadenopathy without a primary cutaneous lesion: a report of 2 cases.
M. Warnick
,
Saurabh Singh
,
M. Boisvert
,
G. Peck
Archives of Dermatology
2008
Corpus ID: 204979460
increased glucose and protein levels. A CSF culture proved negative. The patient’s results of a rapid plasma reagin test were…
Expand
2007
2007
Long-term follow-up of a child treated with efalizumab for atopic dermatitis.
E. Siegfried
Archives of Dermatology
2007
Corpus ID: 45295016
Review
2006
Review
2006
Efalizumab for Psoriasis: A Systematic Review
Jiang-Fang Sun
2006
Corpus ID: 76599695
Objective To assess the efficacy and safety of efalizumab in the treatment of psoriasis.Methods Randomized controlled trials (RCT…
Expand